Dr Svetlana Zaydman, DO | |
2428 E 117th St, Burnsville, MN 55337-1269 | |
(612) 444-3000 | |
(612) 444-9000 |
Full Name | Dr Svetlana Zaydman |
---|---|
Gender | Female |
Speciality | Physical Medicine And Rehabilitation |
Experience | 19 Years |
Location | 2428 E 117th St, Burnsville, Minnesota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285960013 | NPI | - | NPPES |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Valley Pain Relief And Wellness Center Pllc | 7517198211 | 12 |
News Archive
Probiotic supplements are widely available and are sometimes promoted as a general way to support gut microbiome and promote health.
The future of colon cancer screening may be surprisingly simple. ColoMarker, an innovative blood test to detect the early stages of colon cancer is generating plenty of attention from a wide audience, including from some of the world's leading researchers in cancer biomarkers and gastrointestinal medicine.
The Washington Post on Saturday examined the role of the Healthcare Information and Management Systems Society in lobbying for the national adoption of health information technology as part of health reform efforts.
InDepth Pharmaceuticals, founded by Deepak Nihalani, Ph.D., the SmartState Endowed Chair in Renal Disease Biomarkers at the Medical University of South Carolina, has taken a vital step toward commercializing an innovative diagnostic technique that could better predict kidney transplant success in patients with focal segmental glomerulosclerosis (FSGS), a kidney disease that often leads to end-stage renal failure.
› Verified 7 days ago
Entity Name | Valley Pain Relief And Wellness Center Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1871915470 PECOS PAC ID: 7517198211 Enrollment ID: O20140321001462 |
News Archive
Probiotic supplements are widely available and are sometimes promoted as a general way to support gut microbiome and promote health.
The future of colon cancer screening may be surprisingly simple. ColoMarker, an innovative blood test to detect the early stages of colon cancer is generating plenty of attention from a wide audience, including from some of the world's leading researchers in cancer biomarkers and gastrointestinal medicine.
The Washington Post on Saturday examined the role of the Healthcare Information and Management Systems Society in lobbying for the national adoption of health information technology as part of health reform efforts.
InDepth Pharmaceuticals, founded by Deepak Nihalani, Ph.D., the SmartState Endowed Chair in Renal Disease Biomarkers at the Medical University of South Carolina, has taken a vital step toward commercializing an innovative diagnostic technique that could better predict kidney transplant success in patients with focal segmental glomerulosclerosis (FSGS), a kidney disease that often leads to end-stage renal failure.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Svetlana Zaydman, DO 2428 E 117th St, Burnsville, MN 55337-1269 Ph: (612) 444-3000 | Dr Svetlana Zaydman, DO 2428 E 117th St, Burnsville, MN 55337-1269 Ph: (612) 444-3000 |
News Archive
Probiotic supplements are widely available and are sometimes promoted as a general way to support gut microbiome and promote health.
The future of colon cancer screening may be surprisingly simple. ColoMarker, an innovative blood test to detect the early stages of colon cancer is generating plenty of attention from a wide audience, including from some of the world's leading researchers in cancer biomarkers and gastrointestinal medicine.
The Washington Post on Saturday examined the role of the Healthcare Information and Management Systems Society in lobbying for the national adoption of health information technology as part of health reform efforts.
InDepth Pharmaceuticals, founded by Deepak Nihalani, Ph.D., the SmartState Endowed Chair in Renal Disease Biomarkers at the Medical University of South Carolina, has taken a vital step toward commercializing an innovative diagnostic technique that could better predict kidney transplant success in patients with focal segmental glomerulosclerosis (FSGS), a kidney disease that often leads to end-stage renal failure.
› Verified 7 days ago